Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harries

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|October 4, 2012
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapyRobert Goldstein, Catherine M Stefanato, Victoria Warbey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 14, 2025
Systematic review of checkpoint inhibitor-induced epidermal necrolysisRebecca Creamer, Freya Hamar-Davies, Mark Harries, et al.
Melanoma Research|August 19, 2011
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceRachel Angharad Abbott, Katharine M Acland, Mark Harries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?Arnie Purushotham, Sarah Pinder, Massi Cariati, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runnersAlexandra Tomkinson, Jane H Gibson, Mark Lunt, et al.
Journal of Cutaneous Pathology|June 13, 2009
Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinomaPaul J Craig, Jaime E Calonje, Mark Harries, et al.
European Journal of Dermatology : EJD|September 16, 2016
Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UKLeah Fink, Justyna Amelio, Mark Harries, et al.
Nuclear Medicine Communications|December 20, 2007
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceMichael S Hofman, Anastasia Constantinidou, Katharine Acland, et al.
Melanoma Research|January 30, 2008
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefitAnastasia Constantinidou, Michael Hofman, Michael O'Doherty, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2016
Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in EuropeMark Harries, Josep Malvehy, Céleste Lebbe, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|October 4, 2012
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapyRobert Goldstein, Catherine M Stefanato, Victoria Warbey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 14, 2025
Systematic review of checkpoint inhibitor-induced epidermal necrolysisRebecca Creamer, Freya Hamar-Davies, Mark Harries, et al.
Melanoma Research|August 19, 2011
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceRachel Angharad Abbott, Katharine M Acland, Mark Harries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?Arnie Purushotham, Sarah Pinder, Massi Cariati, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runnersAlexandra Tomkinson, Jane H Gibson, Mark Lunt, et al.
Journal of Cutaneous Pathology|June 13, 2009
Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinomaPaul J Craig, Jaime E Calonje, Mark Harries, et al.
European Journal of Dermatology : EJD|September 16, 2016
Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UKLeah Fink, Justyna Amelio, Mark Harries, et al.
Nuclear Medicine Communications|December 20, 2007
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceMichael S Hofman, Anastasia Constantinidou, Katharine Acland, et al.
Melanoma Research|January 30, 2008
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefitAnastasia Constantinidou, Michael Hofman, Michael O'Doherty, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2016
Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in EuropeMark Harries, Josep Malvehy, Céleste Lebbe, et al.
Pageof 6